STEM CELL THERAPY FOR COMMUNITY ACQUIRED PNEUMONIA INDUCED SEPSIS

SEPCELL Trial Investigator Meeting October 18th, Madrid, Spain.

The SEPCELL trial Investigator Meeting took place in Madrid, Spain, on October 18th organized by TiGenix and with the participation of the SEPCELL national coordinators Dr François, Dr Laterre, Dr Sánchez and Dr van der Poll.

Over thirty clinical investigators and study coordinators attended the meeting, in which the members of the consortium shared further insights on the rationale of using mesenchymal stem cells to treat sepsis, extensively presented the clinical trial protocol, and discussed practical clinical cases for patient selection as well as different logistics and methodological aspects of the study.

We are looking forward to announcing the recruitment of the first patient in due course.

Dr. Laterre and Dr. Sánchez during the Investigator Meeting in Madrid

sepcell-investigator-meeting-news_final2

Over 30 clinical investigators attended the meeting

sepcell-investigator-meeting-news_final3

We use [own and third parties] cookies to analyse the use of our website and improve our services. If you continue visiting the website you are agreeing our cookies policy. You can change the configuration of the cookies and obtain additional information.

MORE INFO